Thema: US05370A1088
RNA, US05370A1088
coin-1549061_1920.jpg - Foto: THN
Avidity Biosciences stock: Novartis defends 12 billion US dollar deal
Avidity Biosciences stock stays under scrutiny after Novartis took a 1.9 billion US dollar impairment tied to del-desiran. The buyer still backs the platform.
ad-hoc-news.de, heute 01:06 Uhr
RNA, US05370A1088
Avidity Biosciences stock crossed below its 200-day average ...
Avidity Biosciences stock sat below its 200-day average October 7, 2026. Second-quarter revenue hit USD 3.00 million versus USD 0.67 million.
ad-hoc-news.de, 14.10.26 03:19 Uhr
RNA, US05370A1088
Avidity Biosciences misses HARBOR endpoint: analysts target ...
